Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Veracyte (VCYT) over the last 6 years, with Dec 2024 value amounting to $0.31.

  • Veracyte's EPS (Weighted Average and Diluted) rose 26.32% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.38, marking a year-over-year increase of 371.43%. This contributed to the annual value of $0.31 for FY2024, which is 130.39% up from last year.
  • Per Veracyte's latest filing, its EPS (Weighted Average and Diluted) stood at $0.31 for FY2024, which was up 130.39% from -$1.02 recorded in FY2023.
  • In the past 5 years, Veracyte's EPS (Weighted Average and Diluted) registered a high of $0.31 during FY2024, and its lowest value of -$1.11 during FY2021.
  • Over the past 3 years, Veracyte's median EPS (Weighted Average and Diluted) value was -$0.51 (recorded in 2022), while the average stood at -$0.41.
  • As far as peak fluctuations go, Veracyte's EPS (Weighted Average and Diluted) plummeted by 144.44% in 2020, and later skyrocketed by 130.39% in 2024.
  • Over the past 5 years, Veracyte's EPS (Weighted Average and Diluted) (Yearly) stood at -$0.66 in 2020, then plummeted by 68.18% to -$1.11 in 2021, then spiked by 54.05% to -$0.51 in 2022, then tumbled by 100.00% to -$1.02 in 2023, then skyrocketed by 130.39% to $0.31 in 2024.